1 / 6

Ewing Sarcoma Pipeline Analysis Based on Route of Administration of Active Drug Candidates

Ewing sarcoma pipeline comprises approximately 29 drug candidates in different stages of development. Ewing sarcoma is a condition in which formation of cancer or tumor takes place in bones and soft tissues. The symptoms associated with Ewing sarcoma include pain as well as swelling in the chest, back, legs, pelvis and arms, lumps in arms, bone fracture, weight loss, loss of appetite, fatigue, malaise, etc.<br><br>The pipeline for Ewing sarcoma was analyzed based on the route of administration and it was found that most of the drug candidates are being developed to be administered by oral route.

NidhiNehani
Download Presentation

Ewing Sarcoma Pipeline Analysis Based on Route of Administration of Active Drug Candidates

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ewing sarcoma Pipeline to Witness Increased R&D Investment in the Coming Years

  2. Ewing Sarcoma Therapeutics According to a new research report “Ewing sarcoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration and Other Developments” published by P&S Market Research, Ewing sarcoma currently exhibits a strong pipeline with approximately 29 drug candidates. Explore Report Description at: https://www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis Ewing sarcoma Pipeline Analysis Ewing sarcoma pipeline comprises approximately 29 drug candidates in different stages of development. Ewing sarcoma is a condition in which formation of cancer or tumor takes place in bones and soft tissues. The symptoms associated with Ewing sarcoma include pain as well as swelling in the chest, back, legs, pelvis and arms, lumps in arms, bone fracture, weight loss, loss of appetite, fatigue, malaise, etc.

  3. Ewing Sarcoma Therapeutics Pipeline Insights The pipeline for Ewing sarcoma was analyzed based on the route of administration and it was found that most of the drug candidates are being developed to be administered by oral route. Major companies collaborate for the development of Ewing sarcoma pipeline The research also found that various companies are engaged in collaborations for Ewing sarcoma. In April 2014, NanoSmart Pharmaceuticals Inc. and NanoValent Pharmaceuticals Inc., entered into a research collaboration agreement to find out the feasibility of jointly developing an ANA-conjugated liposomal doxorubicin nanoparticle for the treatment of ovarian cancer and other solid tumors.

  4. Ewing Sarcoma Therapeutics Novel and patented technologies for Ewing sarcoma pipeline Novel technologies are being used for Ewing sarcoma drug candidates. MacroGenics Inc., has been using Fc Optimization platform for the development of their drug candidates. Some of the key players developing Ewing sarcoma therapeutics include Celgene Corporation, Pfizer Inc., and Novartis AG, and others.

  5. Ewing Sarcoma Therapeutics Download report sample at: https://www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis/report-sample

  6. GET IN TOUCH THANK YOU! For information regarding permissions and other queries Kindly write to: US/Canada Toll-Free: 1-888-778-7886

More Related